Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 3
1946 10
1947 14
1948 8
1949 13
1950 21
1951 29
1952 24
1953 25
1954 24
1955 27
1956 28
1957 21
1958 21
1959 35
1960 22
1961 24
1962 23
1963 26
1964 30
1965 13
1966 1
1967 1
1969 1
1971 1
1972 5
1973 83
1974 396
1975 533
1976 466
1977 424
1978 418
1979 494
1980 446
1981 548
1982 477
1983 510
1984 500
1985 543
1986 578
1987 479
1988 478
1989 519
1990 557
1991 596
1992 583
1993 532
1994 531
1995 494
1996 538
1997 498
1998 524
1999 571
2000 605
2001 735
2002 840
2003 998
2004 1300
2005 1643
2006 1882
2007 2164
2008 2304
2009 2424
2010 2971
2011 3342
2012 3459
2013 3611
2014 3641
2015 3490
2016 3250
2017 3045
2018 2727
2019 1332
2020 29
Text availability
Article attribute
Article type
Publication date

Search Results

53,731 results
Results by year
Filters applied: . Clear all
Page 1
Damoctocog Alfa Pegol: A Review in Haemophilia A
Paik J and Deeks ED. Drugs 2019 - Review. PMID 31218660 Free PMC article.
Formulated with a 60 kDa polyethylene glycol (PEG) moiety, damoctocog alfa pegol is an intravenously (IV) administered recombinant factor VIII (rFVIII) product with a longer terminal half-life than non-PEGylated FVIII and rFVIII products. ...
Formulated with a 60 kDa polyethylene glycol (PEG) moiety, damoctocog alfa pegol is an intravenously (IV) administered recombinant fa …
Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A
Shah A, et al. Ann Hematol 2019 - Clinical Trial. PMID 31236667 Free PMC article.
BAY 94-9027 is an extended-half-life, recombinant factor VIII (rFVIII) product conjugated with a 60-kDa branched polyethylene glycol (PEG) molecule indicated for use in previously treated patients (aged ≥ 12 years) with hemophilia A. ...
BAY 94-9027 is an extended-half-life, recombinant factor VIII (rFVIII) product conjugated with a 60-kDa branched polyethylene glycol …
Mechanical and oral antibiotic bowel preparation versus no bowel preparation for elective colectomy (MOBILE): a multicentre, randomised, parallel, single-blinded trial
Koskenvuo L, et al. Lancet 2019 - Clinical Trial. PMID 31402112
Key exclusion criteria were need for emergency surgery; bowel obstruction; colonoscopy planned during surgery; allergy to polyethylene glycol, neomycin, or metronidazole; and age younger than 18 years or older than 95 years. ...Patients allocated to MOABP prepared their bowel by drinking 2 L of polyethylene glycol and 1 L of clear fluid before 6 pm on the day before surgery and took 2 g of neomycin orally at 7 pm and 2 g of metronidazole orally at 11 pm the day before surgery. ...
Key exclusion criteria were need for emergency surgery; bowel obstruction; colonoscopy planned during surgery; allergy to polyethylene
In Vitro Evaluation of the Biological Availability of Hyaluronic Acid Polyethylene Glycols-Cross-Linked Hydrogels to Bovine Testes Hyaluronidase.
Zerbinati N, et al. Biomed Res Int 2019. PMID 31309104 Free PMC article.
In this article, we analyzed the bioavailability of hyaluronidase degradation of five fillers of Neauvia® hydrogels line (MatexLab SA, Lugano, CH), composed of pure hyaluronic acid and based on PEGDE cross-linking (polyethylene glycol) technology that guarantees a higher biocompatibility and an optimal biointegration and rheological characteristics. ...
In this article, we analyzed the bioavailability of hyaluronidase degradation of five fillers of Neauvia® hydrogels line (MatexLab SA, Lugan …
53,731 results
Jump to page
Feedback